The integration of single cell T-cell receptor (TCR) sequencing has also identified shared gene expression profiles of neoantigen-specific CD8+ and CD4+ T-cells within metastatic human cancers, which may provide useful biomarkers for immunotherapy as well [143]. The gene discussed is CD8A; the disease is cancer.